Efficacy and safety of St. John's wort for the treatment of major depression

Public Health Nutrition

Volumn 3, Issue 4 A, 2000, Pages 487-494

  Nangia, M ^a   Syed, W ^a   Doraiswamy, P M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse events; Clinical trials; Drug interactions; Hyperforin; Hypericum; Major depression

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; INDINAVIR; ORAL CONTRACEPTIVE AGENT;

DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERICUM PERFORATUM; INSOMNIA; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; RELAPSE; RESTLESSNESS; REVIEW; SEDATION; TREATMENT PLANNING; TREMOR; VERTIGO; XEROSTOMIA;

HYPERICUM; HYPERICUM PERFORATUM;

EID: 0034501127     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1368980000000562     Document Type: Review

References (52)

1. The pharmacologic treatment of depression
2. St John's wort for depression
3. Clinical trials with phytopsychopharmacological agents
4. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers
5. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers
6. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract
7. Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity
8. Effects of hypericum extract on expression of serotonin
9. Effects of long term administration of hypericum extracts on the affinity and density of central serotonergic 5-HT1 A and 5-HT2 A receptors
10. Inhibition of benzodiazepine in vitro by amentoflavone, a constituent of various species of Hypericum
11. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding
12. St. John's wort (Hypericum perforatum); Clinical effects on depression and other conditions
13. Neuropharmacology of St. John's Wort (Hypericum). Review
14. Biologically active and other chemical constituents of Hypericum perforatum
15. Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility
16. +
17. St. John's wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy
18. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract
19. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat
20. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus
21. Effect of the Hypericum perforatum extract on serotonin turnover in the mouse brain
22. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat
23. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers
24. St John's wort for depression - An overview and meta-analysis of randomized clinical trials
25. St. John's wort for depression: A meta-analysis of well-defined clinical trials
26. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients a controlled 6-week clinical trial
27. Clinical efficacy and tolerance of the hypericum, special extract LI 160 in depressive disorders - A drug monitoring study 19
28. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild to moderate depression
29. Comparison of equivalence between the St. John's wort extract LoHyp and fluoxetine
30. Potential treatment for subthreshold and mild depression: A comparison of St. John's wort extracts and fluoxetine
31. Treatment of seasonal affective disorder (SAD) with Hypericum extract
32. Hypericum in Seasonal Affective Disorder (SAD)
33. Benefits and risks of the hypericum extract LI 160: Drug-monitoring study with 3250 patients
34. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum)
35. St. John's wort: Three cases of possible mania induction
36. SSRI and St. John's wort: Possible toxicity?
37. Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans
38. Acute neuropathy after exposure to sun in a patient treated with St. John's wort
39. Phototoxic effects of Hypericum extracts in cultures of human keratinocytes compared with those of psoralen
40. The effects of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine
41. Second thoughts about safety of St. John's wort
42. Safety of St. John's wort
43. Indinavir concentrations and St John's wort
44. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers
45. St. John's wort and antidepressant drug interactions in the elderly
46. Herbal remedies: Adverse effects and drug interaction
47. Pharmacokinetic interaction of digoxin with a herbal extract from St. John's wort (Hypericum perforatum)
48. Comparison of St John's wort and imipramine for treating depression